Endothelial Dysfunction: Mechanisms, Cardiovascular Risk, and Assessment
The endothelium is a dynamic interface regulating vascular tone, inflammation, thrombosis, and angiogenesis through mediators like nitric oxide (NO), prostacyclin, and endothelin-1. Endothelial dysfunction—characterized by impaired NO bioavailability—is an early, reversible step toward atherosclerosis.
Pathophysiological Hallmarks
- Impaired vasodilation – Reduced NO leads to vasoconstriction and increased vascular resistance.
- Pro-inflammatory state – Upregulation of adhesion molecules (VCAM-1, ICAM-1) and cytokines.
- Oxidative stress – Reactive oxygen species scavenge NO; uncoupled eNOS produces superoxide.
- Pro-thrombotic shift – Decreased thrombomodulin, increased PAI-1 and von Willebrand factor.
- Impaired angiogenesis – Inadequate collateral formation in ischemic tissues.
Major Risk Factors
- Hypertension, dyslipidemia, diabetes, smoking, obesity, sedentary lifestyle, aging.
Clinical Assessment
- Flow-mediated dilation (FMD) of the brachial artery – gold standard research tool.
- Peripheral arterial tonometry (EndoPAT) – operator-independent alternative.
- Biomarkers: ADMA, endothelin-1, von Willebrand factor.
Therapeutic Targets
Lifestyle interventions (exercise, Mediterranean diet), statins, ACE inhibitors/ARBs, SGLT2 inhibitors, and GLP-1 agonists all improve endothelial function, reducing cardiovascular risk.
Cardiovascular Disease - Related Articles
- Understanding Stents: What They Are and How They Work
- Understanding Blocked Cardiac Arteries: Symptoms & Coronary Artery Disease
- Understanding Healthy Triglyceride Levels: Risks & Management
- Weight Management After Coronary Stent: Protecting Your Heart Investment
- Resting Heart Rate: Why Optimal Is Personal, Not a Fixed Number
- Saturated Fat & Heart Disease: Sources, LDL Effects & Dietary Guidance
- Accurate Home Blood Pressure Monitoring: A Simple Guide
